IDH1 and glioblastoma: The Cancer Genome Atlas (TCGA) has also examined molecular characterics of GBM and has shown that multiple genes (ERBB2, NF1, TP53, PIK3R1, PDGFRA/IDH1, etc.)and pathways possess aberrations that may be clinically relevant [30,31].